ClassID:

92049

C07C65/11 - CPC Classification

Classification description:

Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic with carboxyl groups on a condensed ring system containing two rings

Recent Application in this class:
#1
20260092037
2026-04-02

CRYSTALLINE SALT FORMS OF N-((1-(2-(TERT-BUTYLAMINO)-2-OXOETHYL)PIPERIDIN-4-YL) METHYL)-3-CHLORO-5-FLUOROBENZAMIDE AND METHODS OF USE THEREOF

#2
20260042744
2026-02-12

NICOTINE SALTS, CO-CRYSTALS, AND SALT CO-CRYSTAL COMPLEXES

#3
20260022103
2026-01-22

PRAMIPEXOLE XINAFOATE AND SUSTAINED-RELEASE PHARMACEUTICAL FORMULATION THEREOF

#4
20250249483
2025-08-07

METHOD AND APPARATUS FOR SORTING HETEROGENEOUS MATERIAL

#5
20250163019
2025-05-22

NICOTINE SALTS, CO-CRYSTALS, AND SALT CO-CRYSTAL COMPLEXES

#6
20250129087
2025-04-24

SALT CRYSTALS

#7
20250074886
2025-03-06

NICOTINE SALTS, CO-CRYSTALS, AND SALT CO-CRYSTAL COMPLEXES

#8
20250059195
2025-02-20

TRIAZOLONE DERIVATIVE SALT AS NEUTROPHIL ELASTASE INHIBITOR

#9
20250051340
2025-02-13

TRIAZOLONE DERIVATIVE SALT AS NEUTROPHIL ELASTASE INHIBITOR

#10
20230265044
2023-08-24

SALT OF DEMETHYL TRAMADOL AND USE THEREOF

#11
20230119149
2023-04-20

Method and apparatus for sorting heterogeneous material

#12
20230105412
2023-04-06

5-HT3 RECEPTOR MODULATOR, THE CRYSTALLINE FORM, METHODS OF MAKING, AND USE THEREOF

#13
20220098166
2022-03-31

Nicotine salts, co-crystals, and salt co-crystal complexes

#14
20220095614
2022-03-31

Antibiotic compounds

#15
20210395219
2021-12-23

NICOTINE SALTS, CO-CRYSTALS, AND SALT CO-CRYSTAL COMPLEXES

#16
20210171463
2021-06-10

Design, synthesis and characterization of metal organic frameworks

#17
20210087144
2021-03-25

Insoluble complex or solvate thereof, pharmaceutical composition and use thereof

#18
20200190009
2020-06-18

Antibiotic compounds

#19
20200165182
2020-05-28

Indene derivatives and uses thereof

#20
20200148664
2020-05-14

Nicotine salts, co-crystals, and salt co-crystal complexes

#21
20200129423
2020-04-30

Donezil pamoate, method of preparation and use thereof

#22
20200087277
2020-03-19

Nicotine salts, co-crystals, and salt co-crystal complexes

#23
20190300491
2019-10-03

Salt of quinazoline derivative, preparation method therefor and application thereof

#24
20190274955
2019-09-12

Pamoate salts and methods of use

#25
20190262866
2019-08-29

Method and apparatus for sorting heterogeneous material

#26
20190248742
2019-08-15

Synthesis and characterization of metal organic frameworks

#27
20190204735
2019-07-04

Resist composition, method of forming resist pattern, compound, and acid diffusion control agent

#28
20190169147
2019-06-06

Vortioxetine pamoic acid salt and crystal form thereof

#29
20180200762
2018-07-19

Method and apparatus for sorting heterogeneous material

#30
20180155287
2018-06-07

Compositions and methods for the treatment of inflammation and pain

#31
20180104179
2018-04-19

Memantine pamoate, method of preparation and use thereof

#32
20180051002
2018-02-22

Nicotine salts, co-crystals, and salt co-crystal complexes

#33
20170334881
2017-11-23

Nicotine salts, co-crystals, and salt co-crystal complexes

#34
20170152206
2017-06-01

IRE-1α inhibitors

#35
20170096394
2017-04-06

Design, synthesis and characterization of metal organic frameworks

#36
20170050932
2017-02-23

Salt of ivabradine and process for the preparation thereof

#37
20160229812
2016-08-11

Salt of nitrogen-containing heterocyclic compound or crystal thereof, pharmaceutical composition, and FLT3 inhibitor

#38
20160207886
2016-07-21

Compositions and methods for the treatment of inflammation and pain

#39
20160194287
2016-07-07

Compositions and methods for the treatment of inflammation and pain

#40
20160066603
2016-03-10

FULVIC ACID AND DERIVATIVES AND METHODS OF PREPARATION AND USE

#41
20150344456
2015-12-03

Nicotine salts, co-crystals, and salt co-crystal complexes

#42
20150225349
2015-08-13

Method of preparation of imipramine pamoate and novel crystalline form of imipramine pamoate thereof

#43
20140315952
2014-10-23

Donepezil pamoate, method of preparation and use thereof

#44
20140274984
2014-09-18

ACID ADDITION SALTS OF 5ALPHA-HYDROXY-6BETA-[2-(1H-IMIDAZOL-4-YL)ETHYLAMINO]CHOLESTAN-3BETA-OL

#45
20140244027
2014-08-28

Method and apparatus for sorting recycled material

#46
20140243278
2014-08-28

Acid Addition Salt of Donepezil and Pharmaceutical Composition Thereof

#47
20130203760
2013-08-08

Polymorphs of brimonidine pamoate

#48
20130053573
2013-02-28

2,4,5-TRIAMINOPHENOLS AND RELATED COMPOUNDS

#49
20120022117
2012-01-26

Salts or co-crystals of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol

#50
20120015951
2012-01-19

Polymorphs of brimonidine pamoate

#51
20110253133
2011-10-20

Methods and compositions for administration of oxybutynin

#52
20110237796
2011-09-29

Metal complex and manufacturing method therefor

#53
20110065162
2011-03-17

IRE-1α inhibitors

#54
20100131094
2010-05-27

METHOD AND APPARATUS FOR SORTING HETEROGENEOUS MATERIAL

#55
20100125077
2010-05-20

Polymorphs of brimonidine pamoate

#56
20090186893
2009-07-23

IRE-1α inhibitors

#57
20080293812
2008-11-27

Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates

#58
20080213347
2008-09-04

Ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof

#59
20080167441
2008-07-10

Process for the synthesis of hydroxy aromatic acids

#60
20070015903
2007-01-18

Method of making aromatic dihydroxy diacid dihalides and precipitates resulting therefrom

#61
20070008888
2007-01-11

Direct lookup tables and extensions thereto for packet classification

#62
20060287553
2006-12-21

Method of stabilizing 1,4-dihydroxy-2-naphthoic acid

#63
20060205967
2006-09-14

Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates

#64
20050234131
2005-10-20

Ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof

#65
20050043564
2005-02-24

Process for dehydrating hydrous sodium beta-naphtholate